Literature DB >> 2549190

Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells.

S Mitrani-Rosenbaum1, R Tsvieli, R Tur-Kaspa.   

Abstract

Human papillomavirus (HPV) type 16 is highly associated with cervical cancer, but it seems that cofactors such as hormones affect its potential oncogenicity. We have analysed the HPV-16 gene expression in response to sex hormones and glucocorticoids in SiHa cells, a human cervical carcinoma cell line. An eightfold induction of HPV-16 transcripts was obtained in oestrogen-treated SiHa cells. Of the five HPV-16 transcripts detected in these cells only the two major ones, the 4.6 kb and the 4.1 kb mRNA species, were affected by oestrogen. Since the five transcripts span the E6 and E7 open reading frames of the HPV-16 genome, these results suggest that the expression of the various transcripts is differentially controlled, as oestrogen regulates only two of them. We have identified in the HPV-16 genome seven different regions with a high degree of similarity to the oestrogen-responsive element consensus sequence (GGTCANNNTGACC). These sequences are located throughout the entire HPV-16 genome. Progesterone or dexamethasone had no detectable stimulatory effect on the various transcripts of HPV-16 in SiHa cells, up to 24 h after treatment of the cells. Since the E6 and E7 open reading frames have been associated with the oncogenic potential of HPV-16, the effect of oestrogen on the transcription of these viral genes may be of biological relevance in the malignant transformation of HPV-16-infected cervical cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549190     DOI: 10.1099/0022-1317-70-8-2227

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  33 in total

Review 1.  Estrogen and ERalpha: culprits in cervical cancer?

Authors:  Sang-Hyuk Chung; Silvia Franceschi; Paul F Lambert
Journal:  Trends Endocrinol Metab       Date:  2010-04-22       Impact factor: 12.015

2.  Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene.

Authors:  William W Au; Salama Abdou-Salama; Ayman Al-Hendy
Journal:  Gynecol Oncol       Date:  2006-11-29       Impact factor: 5.482

Review 3.  Cancer-promoting effects of microbial dysbiosis.

Authors:  Amy M Sheflin; Alyssa K Whitney; Tiffany L Weir
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

4.  Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.

Authors:  Amy Baldwin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 5.  Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

6.  Oestrogen receptor transcripts associated with cervical human papillomavirus infection.

Authors:  M L Shew; R McGlennen; N Zaidi; M Westerheim; M Ireland; S Anderson
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

7.  17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.

Authors:  Anna Lutkowska; Andrzej Roszak; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

8.  The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction.

Authors:  Jennifer L Bromberg-White; Craig Meyers
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Requirement for stromal estrogen receptor alpha in cervical neoplasia.

Authors:  Sang-Hyuk Chung; Myeong Kyun Shin; Kenneth S Korach; Paul F Lambert
Journal:  Horm Cancer       Date:  2012-10-13       Impact factor: 3.869

Review 10.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.